Renal cell carcinoma (RCC) is the most common primary cancer arising from the kidney in adults, with clear cell renal cell carcinoma (ccRCC) representing approximately 75% of all RCCs. Increased expression of the hypoxia-induced factors-1a (HIF1a) and HIF2a has been suggested
Introduction
Renal cell carcinoma (RCC) is the most common primary cancer arising from the kidney in adults, with clear cell renal cell carcinoma (ccRCC) representing approximately 75% of all RCCs (1, 2). Loss of expression or mutation of the von Hippel-Lindau (VHL) tumor suppressor gene is found in hereditary and most sporadic ccRCCs (1, 3) . This suggests an etiologic role for VHL gene loss in renal carcinogenesis. However, the exact pathway by which loss of VHL leads to ccRCC has not been elucidated. The best studied and likely the most important effect of VHL loss is the increased expression of the hypoxia-inducible factor-1a (HIF1a) and hypoxia-inducible factor-2a (HIF2a; ref. [4] [5] [6] . Increased expression of these 2 transcription factors has been proposed as a key step in ccRCC carcinogenesis (4) . HIF2a shares approximately 48% amino acid homology with HIF1a (7) . Both HIF1a and HIF2a are regulated by prolyl hydroxylation at proline sites and by asparaginyl hydroxylation at an asparagine site under normoxic conditions (7) , and each pairs with HIF1b and binds to hypoxia responsive elements (HREs, 5 0 -RCGTG-3 0 , ref. 7) . HIF2a protein levels are increased and HIF2a is transcriptionally activated in VHL À/À renal carcinomas (8) . Furthermore, elimination of HIF2a in RCC cell lines is sufficient to suppress VHL À/À tumor growth in xenograft models (9, 10) . Tumor suppression by pVHL can be overridden by HIF2a but not HIF1a in tumor xenografts of cultured 786-0 cells (9, 11, 12) . These data collectively suggest that HIF2a may be more oncogenic than HIF1a for tumor xenograft growth, although other data indicate that HIF1a is more oncogenic (13) (14) (15) (16) (17) (18) .
At present, few murine models that exhibit the pertinent features of human ccRCC exist. Human tumorgraft models of ccRCC have significant limitations, including the immunodeficient state of the animals (19) . We recently reported a transgenic model of cancer of the kidney (TRACK) model, which mimics early-stage human ccRCC through expression of a triple mutant (P402A, P564A, and N803A) human HIF1a construct (13) . We have now used the same kidney proximal tubule specific type 1 g-glutamyl transpeptidase (GGT or gGT) promoter (20, 21) to drive expression of a triple mutant (P405A, P530A, and N851A), constitutively active HIF2a protein specifically in the proximal tubule cells (PTC) to determine if this results in carcinogenesis. We show here that this triple mutant, HIF2a protein (HIF2aM3) is active, even under normoxic conditions. Transgenic mice that express this triple mutant, constitutively active HIF2a construct specifically in the kidney exhibit glycogen accumulation and hydropic degeneration, but no lipid deposition. We also do not observe renal cysts or disorganized proximal tubules resembling in situ carcinoma. We do not observe overexpression of molecular markers of cancer, for example, Ki67, gH2AX, and CD70, in the kidneys of HIF2aM3 transgenic positive (TGþ) mice. Furthermore, we analyzed entire transcriptomes of cells from the HIF2aM3 TGþ kidney cortex by Next Generation Sequencing/RNA-seq. The kidney cortex transcriptome of HIF2aM3 TGþ mice does not closely resemble that of human ccRCC, consistent with the lack of tumorigenesis in these mice.
Materials and Methods

Plasmid construction and generation of transgenic mice
Mutated, constitutively active mouse HIF2a cDNA was created by site-directed mutagenesis (Invitrogen) of conserved proline residues (proline 405 and 530) and a conserved asparagine (asparagine 851) into alanine residues. The rat GGT promoter (À1930-þ246) was amplified by PCR from a plasmid (21) . The GGT promoter, mutated HIF2a, and b-globin poly-A were cloned into pBlueScript and named gGT-HIF2a triple mutant (g-HIF2aM3).
A linearized XhoI-XbaI fragment (vector sequence removed) was injected into pronuclei of one-cell embryos (C57BL/6 x C57BL/6) at the Weill Cornell Medical College (WCMC) Mouse Genetics Core. Southern Blot analysis was then conducted (13) . The g-HIF2aM3 transgene was carried in the heterozygous state. The g-HIF2aM3-1 and the g-HIF2aM3-17 lines were mated with the TRACK mice to obtain g-HIF1aM3; g-HIF2aM3 double TGþ mice. Both g-HIF1aM3 and g-HIF2aM3 transgenes are carried in the heterozygous state in the double TGþ mice. All animal procedures were conducted following guidelines of the Weill Cornell Research Animal Resource Center.
Tissue dissection, processing, pathological review, and histology/staining Tissues were fixed, processed, sectioned, and hematoxylin and eosin stained (13) . Slides were reviewed in a blinded manner by Dr. Shevchuk, an experienced clinical pathologist specializing in human kidney cancer, and independently by a veterinary pathologist, Dr. Linda Johnson, from the Laboratory of Comparative Pathology, WCMC. Immunohistochemistry was carried out as described (13) . Antibodies used: HIF2a (100-122, Novus Biologicals); CA-IX (sc-25600, Santa Cruz); Glut-1 (ab14683, Abcam); Ki67 (M7249, Dako); and gH2AX (9718S, Cell Signaling). Periodic acid-Schiff (PAS) stain was conducted on paraffin-embedded and cryopreserved sections (13) . Oil red O (ORO) staining was performed as described (13) .
Reverse transcriptase PCR, whole genome RNA sequencing, and data analysis Total RNA was extracted using mini-RNAeasy columns (Qiagen). Semiquantitative reverse transcriptase (RT)-PCR was then carried out (13) . Total RNA from thin, outer slices of kidney cortex was used for whole genome sequencing. The complete transcriptomes of kidney cortex from 3 g-HIF2aM3 18-month-old TGþ male mice and 3 age-matched wild-type (WT) C57BL/6 male mice were sequenced on an Illumina HiSeq2000 Sequencer. The reads were aligned to the mouse genome (NCBI37.55/MM9) using the Burrows-Wheeler Aligner (BWA; ref. 22) in GobyWeb software (23) . Comparisons of gene expression changes between g-HIF2aM3 TGþ and WT male mice were carried out using differential expression analysis with Goby in the GobyWeb. Benjamini and Hochberg FDR adjustment (q value) for Student t test (Student t test-BH-FDRq-value) and Benjamini and Hochberg FDR adjustment (q value) for Fisher exact test (Fisher exact test-BH-FDR-q value) were used to determine statistical significance. The data have been in the GEO database (accession no. GSE45254).
Statistical analysis
Results are expressed as the mean AE SEM. Student t test was used to determine the statistical significance of the gH2AXþ and Ki67þ cell number differences between TGþ and WT kidneys.
Results
Generation of transgenic mice that express mutated, constitutively active HIF2a
To examine the role of HIF2a in ccRCC carcinogenesis, we constructed a GGT-HIF2a triple-mutant plasmid (g-HIF2aM3, Fig. 1A ). After confirmation of activity in a cultured normal kidney proximal tubule cell line, a linearized g-HIF2aM3 XbaI-XhoI fragment was used to generate g-HIF2aM3 transgenic mice. A total of 10 of 50 founder mice harbored the integrated target gene by Southern analysis (Fig. 1B , founders #17 to #21). Three lines (#21, #34, and #38) did not show germ line transmission. The other 7 lines were evaluated by RT-PCR, using a transgene-specific primer pair (primers 1 and 2, Fig. 1A ) for transgene mRNA levels in the kidney, spleen, liver, heart, lung, intestine, skeletal muscle, and testis/ovary. The triple-mutant HIF2a (g-HIF2aM3) was expressed only in the kidneys of TGþ lines #1, #17, #27, #31, and #48 (Fig. 1C , TGþ, #1 as an example). The transgene was not expressed in the other organs analyzed, except for low expression in the testis (Fig. 1D) . VHL, endogenous HIF1a, and endogenous HIF2a mRNA levels were not changed in the kidneys of TGþ mice compared with the kidneys of transgenic negative (TGÀ) mice (Fig. 1C, TGÀ) . All 5 TGþ founder lines, g-HIF2aM3-1, g-HIF2aM3-17, g-HIF2aM3-27, g-HIF2aM3-31, and g-HIF2aM3-48, developed normally and could pass the transgene to offspring following a Mendelian pattern of inheritance. Because the GGT promoter is not active until about 3 weeks after birth (20, 21), we did not expect and did not observe any gross developmental abnormalities in the kidneys.
HIF2a and its target genes are upregulated in TGþ kidneys
As described above, the HIF2a transgene mRNA is expressed in TGþ kidneys (Fig. 1C) . We next examined the expression by semiquantitative RT-PCR of CA-IX (NP_647466) and Glut-1 (NP_035530), which are HIF target genes, and CD70 (TNFSF7), which is a marker of human ccRCC (24-27) but not a known HIF2a target gene. We detected increased mRNA levels of CA-IX and Glut-1, but not CD70 ( Fig. 2A) .
By immunohistochemistry, we confirmed increased HIF2a, CA-IX, and Glut1 protein staining in the abnormal proximal tubules (Fig. 2B , C, D, TGþ), but not in the morphologically normal proximal tubules of the same g-HIF2aM3 mice. As expected, weak or no detectable HIF2a, CA-IX, or Glut1 signals are observed in the proximal tubules of TGÀ and WT mice (Fig. 2B , C, D, TGÀ).
g-HIF2aM3-1 and g-HIF2aM3-17 TGþ mice exhibit mild vacuolation Clear vacuoles were detected circumferentially around some, but not all, proximal tubule cell nuclei in the g-HIF2aM3 mice. The g-HIF2aM3-1 and g-HIF2aM3-17 lines exhibited the strongest phenotype (Fig. 3A) ; the other lines had similar phenotypes, but displayed fewer proximal tubules containing clear vacuoles (data not shown). We identified vacuoles with a pale, eosinophilic to clear feathery cytoplasm without displacement of the nucleus, consistent with glycogen accumulation and hydropic degeneration (Fig. 3A , arrows) in one-year-old g-HIF2aM3-1 and g-HIF2aM3-17 mice. Increased numbers of vacuoles in some proximal tubules were observed in 2-year-old g-HIF2aM3-1 and g-HIF2aM3-17 mice (Fig. 3B, arrows) . The histologically abnormal proximal tubule cells in TGþ mice were large, simple cuboidal epithelial cells ( Fig. 3A and B) , and these cells were surrounded by a tubular basement membrane, suggesting that these cells are under proper growth control. In ccRCC, the clear cytoplasm is caused by deposition of glycogen, phospholipids, and neutral lipids, particularly cholesterol esters (28) . The cytoplasm of the abnormal cells in the HIF2a TGþ mice contained increased amounts of glycogen, as showen by PAS staining (Fig. 3C, arrows) , but no increase in lipid as determined by ORO staining (Fig. 3D) .
We examined 21 mice of the g-HIF2aM3-1 line and 16 g-HIF2aM3-17 TGþ mice and compared them with WT mice. The oldest examined was a 33-month-old TGþ male mouse. Six TGþ mice older than 24 months, 13 between the ages of 18 and 24 months, 9 between the ages of 12 and 18 months, and 9 younger than 12 months were analyzed. No renal cysts or disorganized proximal tubules resembling in situ carcinoma were identified in any of the 37 TGþ animals examined.
Expression of markers of proliferation and DNA double strand breaks in the g-HIF2aM3 TGþ mice
Uncontrolled cell division/proliferation is one of the most prominent features of tumor cells. Genomic instability is another universal feature of tumor cells (29) . An increased DNA mutation rate/genomic instability may cause neoplastic transformation (30) . Ki67 is a marker for proliferation (31) . The Research.
GGT promoter
on June 5, 2017. © 2013 American Association for Cancer cancerres.aacrjournals.org Downloaded from serine 139 phosphorylated form of H2A histone family, member X (gH2AX) is a widely used marker that indicates double strand breaks (DSB). We examined Ki67 and gH2AX protein levels in TGþ versus TGÀ kidneys (Fig. 4) . We detected few Ki67þ and gH2AXþ cells in WT proximal tubules (1.5 or 1.9 TGÀ cells/field, respectively). In the g-HIF2aM3 TGþ mice, we observed statistically significantly decreased numbers of Ki67þ and gH2AXþ cells in the morphologically abnormal proximal tubules. There were 0.1 (P ¼ 0.01, compared with TGÀ) and 0.3 (P ¼ 0.02, compared with TGÀ) Ki67þ cells/field in the g-HIF2aM3-1 and g-HIF2aM3-17 TGþ kidneys, respectively; there were 0.9 (P ¼ 0.03, compared with TGÀ) and 0.8 (P ¼ 0.005, compared with TGÀ) gH2AXþ cells/field in the g-HIF2aM3-1 and g-HIF2aM3-17 TGþ kidneys, respectively. Thus, the kidneys from TGþ mice exhibited a reduction in Ki67 and gH2AX staining relative to WT.
The transcriptome of g-HIF2aM3 TGþ kidneys does not closely resemble the transcriptome of human ccRCC
We next examined gene expression using next generation sequencing of the whole transcriptome (RNA-seq). We cut a thin slice of kidney cortex, which contains the preponderance of proximal tubules, and extracted total RNA for whole transcriptome analysis. High levels of proximal tubule marker mRNAs, for example, GGT, indicate kidney cortex identity.
We identified upregulation of 1,253 and downregulation of 749 transcripts in g-HIF2aM3 TGþ versus WT kidney cortexes from 18-month-old mice using less stringent conditions (fold change > 1.2, Student t test-BH-FDR-q value < 0.05, Fisher exact test-BH-FDR-q-value < 0.05). We identified upregulation of 206 and downregulation of 86 transcripts in g-HIF2aM3 TGþ versus WT mice when data were filtered with a more stringent condition (fold change
To compare the transcriptome of the g-HIF2aM3 TGþ kidneys to human ccRCC, we identified the 20 genes most highly overexpressed at the RNA level in human ccRCC from Oncomine (Compendia Bioscience), combining 5 different datasets of human ccRCC patient samples (34) (35) (36) (37) . We identified a total of 5 datasets of cancer versus normal analysis of the ccRCC cancer type ( Table 1 ). The 5 datasets we used are in Table 1 . One of the 20 genes highly expressed in human ccRCC, EGLN3, shows significant upregulation in our g-HIF2aM3 TGþ kidneys (> 3 fold; ref. Table 1 ccRCC are either not changed (P < 0.05) or are not significantly upregulated (< 3 fold) in the g-HIF2aM3 TGþ compared with WT kidneys (Table 1) . We also identified the top genes overexpressed at the RNA level in the g-HIF2aM3 TGþ compared with WT kidneys, and compared the transcript levels of these genes with those in the combined Oncomine datasets used in Table 1 . One of these genes, CD163 molecule-like 1, shows overexpression (fold change > 3) in the combined Oncomine datasets ( Table  2) . The other 19 genes that are highly overexpressed in the g-HIF2aM3 TGþ relative to WT kidneys do not show overexpression in the combined Oncomine human ccRCC versus normal datasets (Table 2) . We conclude from analysis of these data that expression of a mutant, constitutively active HIF2a protein in kidney proximal tubules does not result in a transcriptome that closely resembles that of human ccRCC.
Kidneys from g-HIF1aM3(TRACK); g-HIF2aM3 double TGþ mice are similar to kidneys from g-HIF1aM3 TGþ mice
We also examined kidneys from 8 g-HIF1aM3; g-HIF2aM3 double TGþ male mice (from 6-to 11-months-old). Both HIF1aM3 and HIF2aM3 transgenes are expressed in the kidneys from the g-HIF1aM3; g-HIF2aM3 double TGþ, as detected by RT-PCR using transgene-specific primers (Fig.  5A) . We did not detect CD70 transcripts in these double TGþ kidneys (Fig. 5A ), but we did detect CD70 transcripts in the kidneys of 15-month-old TRACK kidneys, as reported (13) . Seven of 8 g-HIF1aM3; g-HIF2aM3 TGþ mice did not show any greater tumorigenesis in the kidney cortex than the g-HIF1aM3 single TGþ TRACK mice. One of the double TGþ mice had kidneys with a few disorganized proximal tubules (Fig. 5B) , resembling those observed in TRACK mice ages 14 months or older (13) . Because 7 of the 8 g-HIF1aM3; g-HIF2aM3 double TGþ mice showed no pathologic features indicative of greater tumorigenicity than that in the TRACK mice, which express only a mutated, constitutively active from of HIF1a, we conclude that a mutated, constitutively active form of HIF2a does not promote tumorigenesis in the presence of a constitutively active HIF1a in the kidney proximal tubules.
Discussion
The g-HIF2aM3 TGþ kidneys do not resemble human ccRCC histologically
Several researchers have suggested that overexpression of HIF2a is a key step in the development of ccRCC (4). However, we detected no obvious ccRCC phenotype in the kidneys of g-HIF2aM3 TGþ mice. In contrast, in our g-HIF1a-M3 (TRACK) transgenic mice, we identified 2 types of vacuolation: large round, discrete vacuoles, displacing the nucleus, that contained lipid accumulation (13) ; and vacuoles with a pale, eosinophilic to clear feathery cytoplasm without displacement of the nucleus, consistent with glycogen accumulation and hydropic degeneration (13) . Although some PTCs of these g-HIF2aM3 transgenic mice contain clear spaces around the nuclei, the vacuoles do not resemble the large, almost completely clear vacuoles found in the TRACK kidneys (13) and in human ccRCC (38) . Furthermore, no renal cysts or disorganized proximal tubules resembling in situ carcinoma were identified in any of the 37 TGþ animals examined, including 6 between 24-and 33-months-old. These data suggest that overexpression of HIF2a alone in PTCs does not result in PTCs that resemble ccRCC histologically.
The g-HIF2aM3 TGþ kidneys do not show neoplastic transformation and do not express cancer markers
That there is no ccRCC phenotype in these g-HIF2aM3 TGþ kidneys is unexpected, given previous data in the literature using cultured human ccRCC cells (9-12, 32, 33, 39) . HIF2a has previously been reported to be more oncogenic than HIF1a and to play an important role in ccRCC carcinogenesis (4, 40, 41) . However, we detected no renal cysts or neoplasia in the kidneys of g-HIF2aM3 TGþ mice. In contrast, we observed multiple renal cysts and disorganized proximal tubules resembling in situ carcinoma in the g-HIF1a-M3 TGþ TRACK mice (13) . Uncontrolled cell division/proliferation and genomic instability are two of the most prominent features of tumor cells. By staining, using Ki67 or gH2AX antibodies, we previously showed elevated expression of both Ki67 and gH2AX in g-HIF1a-M3 TGþ mice (13) . However, we did not detect higher levels of Ki67 or gH2AX in the g-HIF2aM3 TGþ kidneys (Fig. 4) . In fact, the levels were lower than in WT, suggesting that constitutively active HIF2a reduces cell proliferation and genomic instability. The CD70 protein level is higher in the majority of human ccRCC and CD70 is a marker and therapeutic target in human ccRCC (24) . CD70 mRNA levels are several fold higher in older TRACK versus WT mice (13) . However, we did not observe any CD70 mRNA expression in 18-month-old g-HIF2aM3 TGþ kidneys by RT-PCR (Fig. 2) , again indicating a lack of neoplastic transformation.
Using the methods described in the supplementary data, we calculated and compared the relative levels of the HIF1aM3 and HIF2aM3 transcripts in the HIF1aM3 TGþ (TRACK) mice 
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NOTE: The list of the top 20 genes overexpressed at the mRNA level in the g-HIF2a-M3 TGþ versus WT kidneys was compiled from the RNAseq results. The median fold change in mRNA levels of these genes in human ccRCC was compiled by Oncomine by combining 5 different sets of human ccRCC patient samples, totaling 175 patients (see Table 1 ). Genes that have no measurements from all 5 datasets were excluded from this list.
and HIF2aM3 TGþ mice, respectively. The HIF2aM3 mRNA levels in the HIF2aM3 TGþ mice are about 26% of the HIF1aM3 mRNA levels in the highest expressing TRACK line, and about the same as the HIF1aM3 mRNA levels in other TRACK transgenic lines (Supplementary Table S2 ). The HIF2aM3 protein is also overexpressed in the HIF2aM3 kidneys (Fig. 2B) . Thus, the difference we observe in tumorigenic phenotype is likely a result of the specific HIF protein expressed and not the level of transgene expression.
The transcriptome of g-HIF2aM3 TGþ kidneys does not closely resemble the transcriptome of human ccRCC Furthermore, we compared the changes in gene expression in the g-HIF2aM3 TGþ kidneys with human ccRCC. Only one of the top 20 genes overexpressed in 5 different sets of human ccRCC patient samples showed statistically significant overexpression in the g-HIF2aM3 TGþ kidneys (Table 1) . In fact, some of these genes showed a statistically significant reduction in expression, for example, caveolin 1 showed a fold change of 0.79 (Student t test-BH-FDR-q-value ¼ 0.04) when we compared the g-HIF2aM3 TGþ with WT kidneys. Conversely, only one of the top 20 genes overexpressed at the RNA level in the g-HIF2aM3 TGþ kidneys showed overexpression in the combined human ccRCC Oncomine datasets (Table 2) . These data further indicate that expression of mutated, constitutively active HIF2a in kidney PTCs does not lead to a phenotype resembling human ccRCC, though some HIF2a target genes, such as CA-IX, show increased expression in the PTCs of kidneys of g-HIF2aM3 TGþ mice (Fig. 2) . We did not detect high levels of the putative HIF2a targets TGFa, cyclin D1, and Oct4 (42, 43) in the HIF2aM3 TGþ mice. This might be because different types of cells were used in those assays. For example, Oct4 was identified as a HIF2a target in embryonic stem cells (42) , whereas TGFa and cyclin D1 were identified as HIF2a targets in cultured ccRCC cancer cells (43) .
Expression of constitutively active HIF2a does not cause neoplastic transformation of proximal tubule cells
Our data suggest that expression of a mutated, constitutively active HIF2a in proximal tubule cells, the cells from which ccRCC originates (44, 45) , does not cause neoplastic transformation. This conclusion is also supported by a recent publication reporting that overexpression of a similarly mutated (P405A, P530G, and N851A), constitutively active HIF2a in murine distal tubule cells is insufficient for renal carcinogenesis (16). However, it is possible that HIF2a may cooperate with HIF1a to drive renal cell carcinogenesis, because an increase in HIF2a expression is seen after an increase in HIF1a expression in early kidney lesions in patients with VHL disease (46) . We crossed our TRACK and g-HIF2aM3 TGþ mice to determine whether constitutive activation of both HIF1a and HIF2a results in more rapid neoplastic transformation of normal PTCs. From pathologic examination of 8 g-HIF1aM3; g-HIF2aM3 TGþ mice up to 11 months old, we conclude that constitutively active HIF2a does not result in more rapid neoplastic transformation in the presence of constitutively active HIF1a in the kidney. However, we can not rule out the possibility that this lack of tumorigenicity of HIF2aM3 is caused by potential biologic differences between human and mouse kidney PTCs.
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